Academic Background
Scientific Publications
1.ÇEKİN RUHPER, ARICI SERDAR, ATCI MUHAMMED M., SEÇMELER ŞABAN, CİHAN ŞENER (2020). The Clinical İmportance of Fibroblast Growth Factor 23 on Breast Cancer Patients. Eurasian Journal of Medical Investigation, 4(4), 471-476., Doi: 10.14744/ejmi.2020.30241 (Yayın No: 6944671)
2. YASİN KUTLU; RUHPER CEKİN; SABİN GOKTAS AYDİN; ABDALLAH T M SHBAİR; AHMET BİLİCİ; SERDAR ARİCİ; BALA BASAK OVEN; OZGUR ACİKGOZ; ERKAN OZCAN; OMER FATİH OLMEZ; ASLİ CAKİR; MESUT SEKER (2023).Prognostıc Sıgnıfıcance of Her2 Loss After Her2-Targeted Neoadjuvant Treatment ın Patıents wıth Her2-Posıtıve Locally Advanced Breast Cancer; Clinical and Translational Oncology
3.ARICI SERDAR, ÇEKİN RUHPER (2020). Neutrophil-to-Lymphocyte Ratio May Guide the Choice of Treatment in Metastatic Cancer Patients: Chemotherapy or Best Supportive Care. Archives of Clinical and Experimental Medicine, 5(3), 111-115., Doi: 10.25000/acem.803359 (Yayın No: 6655476)
4. ARICI SERDAR, ŞENGİZ ERHAN SELMA, GEREDELİ ÇAĞLAYAN, ATÇI MUHAMMED MUSTAFA, SEÇMELER ŞABAN, ÇEKİN RUHPER, SAKİN ABDULLAH, CİHAN ŞENER (2021). The Prognostic Importance of Microsatellite Instability Status in Turkish Stage II and III Gastric Cancer Patients who Received Adjuvant Chemotherapy. ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI (International Journal of Hematology and Oncology), 31(1), 36-42., Doi: 10.4999/uhod.214457 (Yayın No: 6938840)
5. ARICI SERDAR, Karyagar Sevda S., uslu erdemir rabia, Çekin Ruhper, Atci Muhammed M., güven osman, Karyagar Savas, CİHAN ŞENER (2021). La correlación entre los marcadores tumorales y los hallazgos de Ga-68DOTA-TATE PET/TC en pacientes con cáncer medular de tiroides avanzado. Revista Española de Medicina Nuclear e Imagen Molecular, Doi: 10.1016/j.remn.2020.03.012 (Yayın No: 6658723)
6. ARICI SERDAR, HAMDARD JAMSHID, SAKİN ABDULLAH, ŞENGİZ ERHAN SELMA, ATCI MUHAMMED M., ÇEKİN RUHPER, SAKA BURCU, KÖSE EMİN, SAYDAM TUBA, GEREDELİ ÇAĞLAYAN, CİHAN ŞENER, BİLİCİ AHMET (2021). The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment. Colorectal Disease, 23(1), 206-212., Doi: 10.1111/codi.15389 (Yayın No: 6655446)
7. ARICI SERDAR, SAKİN ABDULLAH, ÇEKİN RUHPER, SEÇMELER ŞABAN, YAŞAR NURGÜL, CİHAN ŞENER (2021). Does the Waiting Period for Genetic Tests Affectthe Prognosis in ChemotherapyTreated de novoMetastatic Non-Small Cell Lung Cancer Patientswithout a Driver Mutation?. Oncology Research and Treatment, 44(1), 12-18., Doi: 10.1159/000511773 (Yayın No: 6658674)
8. ARICI SERDAR, ŞENGİZ ERHAN SELMA, GEREDELİ ÇAĞLAYAN, ÇEKİN RUHPER, SAKİN ABDULLAH, CİHAN ŞENER (2020). The Clinical Importance of Androgen Receptor Status in Response to Neoadjuvant Chemotherapy in Turkish Patients with Local and Locally Advanced Breast Cancer. Oncology Research and Treatment, 43(9), 435-440., Doi: 10.1159/000508478 (Yayın No: 6655367)
9. ARICI SERDAR,GEREDELİ ÇAĞLAYAN,SEÇMELER ŞABAN,ÇEKİN RUHPER,SAKİN ABDULLAH,CİHAN ŞENER (2020). The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy. Current Problems in Cancer, 44(1), 100485, Doi: 10.1016/j.currproblcancer.2019.05.007 (Yayın No: 6646380)
10. MUHAMMED MUSTATFA ATCI, ÇAĞLAYAN GEREDELİ, SEVAL AY, BİRAY ERTÜRK, ŞABAN SEÇMELER, SERDAR ARICI, RUHPER ÇEKİN (2021) .Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study, European Journal of Breast Health, Vol 17, Iss 2, Pp 123-127 (2021), European Journal of Breast Health, Vol 17, Iss 2, Pp 123-127 (2021)
Ulusal hakemli dergilerde yayımlanan makaleler
1. ARICI SERDAR, ÇEKİN RUHPER, SEÇMELER ŞABAN, ATCI MUHAMMED M., OCAK BİROL, SAKİN ABDULLAH, CİHAN ŞENER (2020). The Clinical Importance of Fibroblast Growth Factor 23 onAdvanced Non-small Cell Lung Cancer Patients WithoutDruggable Alterations in Genes as EGFR or ALK or ROS1Fibroblast Growth Factor 23 and Non-small Cell Lung Cancer. Eurasian Journal of Medical Investigation, 4(3), 365-369., Doi: : 10.14744/ejmi.2020.60165 (Kontrol No: 6655509)
2. CİHAN ŞENER, ARICI SERDAR, ÇEKİN RUHPER (2018). Novel Advances in Oncology. European Archives of Medical Research, 34, 7-9., Doi: 10.5152/eamr.2018.72473 (Kontrol No: 6944726)
1.ÇEKİN RUHPER, ARICI SERDAR, ATCI MUHAMMED M., SEÇMELER ŞABAN, CİHAN ŞENER (2020). The Clinical İmportance of Fibroblast Growth Factor 23 on Breast Cancer Patients. Eurasian Journal of Medical Investigation, 4(4), 471-476., Doi: 10.14744/ejmi.2020.30241 (Yayın No: 6944671)
2. YASİN KUTLU; RUHPER CEKİN; SABİN GOKTAS AYDİN; ABDALLAH T M SHBAİR; AHMET BİLİCİ; SERDAR ARİCİ; BALA BASAK OVEN; OZGUR ACİKGOZ; ERKAN OZCAN; OMER FATİH OLMEZ; ASLİ CAKİR; MESUT SEKER (2023).Prognostıc Sıgnıfıcance of Her2 Loss After Her2-Targeted Neoadjuvant Treatment ın Patıents wıth Her2-Posıtıve Locally Advanced Breast Cancer; Clinical and Translational Oncology
3.ARICI SERDAR, ÇEKİN RUHPER (2020). Neutrophil-to-Lymphocyte Ratio May Guide the Choice of Treatment in Metastatic Cancer Patients: Chemotherapy or Best Supportive Care. Archives of Clinical and Experimental Medicine, 5(3), 111-115., Doi: 10.25000/acem.803359 (Yayın No: 6655476)
4. ARICI SERDAR, ŞENGİZ ERHAN SELMA, GEREDELİ ÇAĞLAYAN, ATÇI MUHAMMED MUSTAFA, SEÇMELER ŞABAN, ÇEKİN RUHPER, SAKİN ABDULLAH, CİHAN ŞENER (2021). The Prognostic Importance of Microsatellite Instability Status in Turkish Stage II and III Gastric Cancer Patients who Received Adjuvant Chemotherapy. ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI (International Journal of Hematology and Oncology), 31(1), 36-42., Doi: 10.4999/uhod.214457 (Yayın No: 6938840)
5. ARICI SERDAR, Karyagar Sevda S., uslu erdemir rabia, Çekin Ruhper, Atci Muhammed M., güven osman, Karyagar Savas, CİHAN ŞENER (2021). La correlación entre los marcadores tumorales y los hallazgos de Ga-68DOTA-TATE PET/TC en pacientes con cáncer medular de tiroides avanzado. Revista Española de Medicina Nuclear e Imagen Molecular, Doi: 10.1016/j.remn.2020.03.012 (Yayın No: 6658723)
6. ARICI SERDAR, HAMDARD JAMSHID, SAKİN ABDULLAH, ŞENGİZ ERHAN SELMA, ATCI MUHAMMED M., ÇEKİN RUHPER, SAKA BURCU, KÖSE EMİN, SAYDAM TUBA, GEREDELİ ÇAĞLAYAN, CİHAN ŞENER, BİLİCİ AHMET (2021). The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment. Colorectal Disease, 23(1), 206-212., Doi: 10.1111/codi.15389 (Yayın No: 6655446)
7. ARICI SERDAR, SAKİN ABDULLAH, ÇEKİN RUHPER, SEÇMELER ŞABAN, YAŞAR NURGÜL, CİHAN ŞENER (2021). Does the Waiting Period for Genetic Tests Affectthe Prognosis in ChemotherapyTreated de novoMetastatic Non-Small Cell Lung Cancer Patientswithout a Driver Mutation?. Oncology Research and Treatment, 44(1), 12-18., Doi: 10.1159/000511773 (Yayın No: 6658674)
8. ARICI SERDAR, ŞENGİZ ERHAN SELMA, GEREDELİ ÇAĞLAYAN, ÇEKİN RUHPER, SAKİN ABDULLAH, CİHAN ŞENER (2020). The Clinical Importance of Androgen Receptor Status in Response to Neoadjuvant Chemotherapy in Turkish Patients with Local and Locally Advanced Breast Cancer. Oncology Research and Treatment, 43(9), 435-440., Doi: 10.1159/000508478 (Yayın No: 6655367)
9. ARICI SERDAR,GEREDELİ ÇAĞLAYAN,SEÇMELER ŞABAN,ÇEKİN RUHPER,SAKİN ABDULLAH,CİHAN ŞENER (2020). The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy. Current Problems in Cancer, 44(1), 100485, Doi: 10.1016/j.currproblcancer.2019.05.007 (Yayın No: 6646380)
10. MUHAMMED MUSTATFA ATCI, ÇAĞLAYAN GEREDELİ, SEVAL AY, BİRAY ERTÜRK, ŞABAN SEÇMELER, SERDAR ARICI, RUHPER ÇEKİN (2021) .Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study, European Journal of Breast Health, Vol 17, Iss 2, Pp 123-127 (2021), European Journal of Breast Health, Vol 17, Iss 2, Pp 123-127 (2021)
Ulusal hakemli dergilerde yayımlanan makaleler
1. ARICI SERDAR, ÇEKİN RUHPER, SEÇMELER ŞABAN, ATCI MUHAMMED M., OCAK BİROL, SAKİN ABDULLAH, CİHAN ŞENER (2020). The Clinical Importance of Fibroblast Growth Factor 23 onAdvanced Non-small Cell Lung Cancer Patients WithoutDruggable Alterations in Genes as EGFR or ALK or ROS1Fibroblast Growth Factor 23 and Non-small Cell Lung Cancer. Eurasian Journal of Medical Investigation, 4(3), 365-369., Doi: : 10.14744/ejmi.2020.60165 (Kontrol No: 6655509)
2. CİHAN ŞENER, ARICI SERDAR, ÇEKİN RUHPER (2018). Novel Advances in Oncology. European Archives of Medical Research, 34, 7-9., Doi: 10.5152/eamr.2018.72473 (Kontrol No: 6944726)